LifeMD Inc reports results for the quarter ended June 30 - Earnings Summary

LifeMD

06/08/2026 06:04

LifeMD Inc LFMD.OQ reported a quarterly adjusted loss of 16 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -6 cents.  The mean expectation of eight analysts for the quarter was for a loss of 15 cents per share. Wall Street expected results to range from -24 cents to -9 cents per share.
Revenue fell 24% to $47.28 million from a year ago; analysts expected $49.10 million. 
LifeMD Inc's reported EPS for the quarter was a loss of 16 cents​.
The company reported a quarterly loss of $7.86 million.
LifeMD Inc shares had fallen by 5.6% this quarter and gained 14.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 23.1% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for LifeMD Inc is $9.50, about 61.3% above its last closing price of $3.68
This summary was machine generated from LSEG data August 6 at 05:04 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.15
-0.16
Missed
Mar. 31 2026 
-0.22
-0.20
Beat
Dec. 31 2025 
-0.03
-0.04
Missed
Sep. 30 2025 
-0.05
-0.07
Missed